Biocept (BIOC) Tops Q3 EPS by 4c

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($0.43), $0.04 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $2.51 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M